Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2009

01.11.2009 | Original Article

Factors Contributing to Hospitalization for Gastroparesis Exacerbations

verfasst von: Sesha S. Uppalapati, Zeeshan Ramzan, Robert S. Fisher, Henry P. Parkman

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

The clinical course of patients with gastroparesis is characterized by symptomatic exacerbations often necessitating hospitalization.

Aims

To investigate precipitating factors leading to hospitalization for exacerbation of symptoms in patients with gastroparesis.

Methods

This was a retrospective review of 103 admissions (63 patients) for gastroparesis exacerbation.

Results

Etiologic categories for gastroparetic patients were diabetic (43%), idiopathic (39%), and post surgical (8%). Poor glycemic control was present in 36%, infection in 19% (12 urinary tract infections and two bacteremia), and noncompliance with or intolerance of, medications in six and 5% of patients, respectively. Fasting morning cortisol concentrations were <3 mcg/dl in 9%. Elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were seen in 34 of 65 (52%) and 11 of 50 patients (22%), respectively. No identifiable infection was found in 74 and 45% of patients with elevated ESR and elevated CRP, respectively. ESR and CRP were higher when patients were symptomatic necessitating hospitalization (26.2 ± 6.6 mm/h and 1.6 ± 1.0 mg/l) compared with when they were seen in outpatient follow-up and less symptomatic (10.3 ± 2.9 mm/h and 0.3 ± 0.1 mg/l; P = 0.0001 and P = 0.211, respectively).

Conclusions

Poor glycemic control, infection, noncompliance with/intolerance of medications, and, perhaps, adrenal insufficiency were contributory factors leading to hospitalizations of gastroparetic patients. Hospitalized patients with gastroparesis exacerbations had elevated ESR and CRP levels. Although many patients with elevated inflammatory markers had evidence of infection, some did not. Assessment of inflammatory markers may help indicate those gastroparetic patients in whom a search for infection should be undertaken.
Literatur
1.
Zurück zum Zitat Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–1591.CrossRefPubMed Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–1591.CrossRefPubMed
2.
Zurück zum Zitat Park M, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006;101:1129–1139.CrossRefPubMed Park M, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006;101:1129–1139.CrossRefPubMed
3.
Zurück zum Zitat Horowitz M, O’Donovan D, Jones KL, et al. Gastric emptying in diabetes clinical significance and treatment. Diabet Med. 2002;19:177–194.CrossRefPubMed Horowitz M, O’Donovan D, Jones KL, et al. Gastric emptying in diabetes clinical significance and treatment. Diabet Med. 2002;19:177–194.CrossRefPubMed
4.
Zurück zum Zitat Koch K. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus—a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999;44(6):1061–1075.CrossRefPubMed Koch K. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus—a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999;44(6):1061–1075.CrossRefPubMed
5.
Zurück zum Zitat Wang WR, Fisher RS, Parkman HP. Gastroparesis related hospitalizations in the United States: trends, characteristics and outcomes, 1995–2004. Am J Gastroenterol. 2008;103(2):313–322.CrossRefPubMed Wang WR, Fisher RS, Parkman HP. Gastroparesis related hospitalizations in the United States: trends, characteristics and outcomes, 1995–2004. Am J Gastroenterol. 2008;103(2):313–322.CrossRefPubMed
6.
Zurück zum Zitat Harberson J, Thomas R, Harbison S, Meilahn J, Parkman HP. Pathology of gastroparesis: assessment of the myenteric plexus and interstitial cells of Cajal. Neurogastroenterol Motil. 2007;19(5):427. (abstract). Harberson J, Thomas R, Harbison S, Meilahn J, Parkman HP. Pathology of gastroparesis: assessment of the myenteric plexus and interstitial cells of Cajal. Neurogastroenterol Motil. 2007;19(5):427. (abstract).
7.
Zurück zum Zitat Martin ST, Collins CG, Fitzgibbon J, et al. Gastric motor dysfunction: is eosinophilic mural gastritis a causative factor? Eur J Gastroenterol Hepatol. 2005;17(9):983–986.CrossRefPubMed Martin ST, Collins CG, Fitzgibbon J, et al. Gastric motor dysfunction: is eosinophilic mural gastritis a causative factor? Eur J Gastroenterol Hepatol. 2005;17(9):983–986.CrossRefPubMed
8.
Zurück zum Zitat De Giorgio R, Barbara G, Stanghellini V, et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol. 2000;12(6):613–616.CrossRefPubMed De Giorgio R, Barbara G, Stanghellini V, et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol. 2000;12(6):613–616.CrossRefPubMed
9.
Zurück zum Zitat Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18(4):641–661.CrossRefPubMed Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18(4):641–661.CrossRefPubMed
10.
Zurück zum Zitat Pande H, Lacy B, Crowell M. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci. 2002;47(12):2664–2668.CrossRefPubMed Pande H, Lacy B, Crowell M. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci. 2002;47(12):2664–2668.CrossRefPubMed
11.
Zurück zum Zitat American Diabetes Association. Executive summary: standards of medical care in diabetes-2008. Diabetes Care. 2008;31(1):S5–S11.CrossRef American Diabetes Association. Executive summary: standards of medical care in diabetes-2008. Diabetes Care. 2008;31(1):S5–S11.CrossRef
12.
Zurück zum Zitat Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology. 1988;94:739–744.PubMed Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology. 1988;94:739–744.PubMed
14.
Zurück zum Zitat Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:675–680.CrossRefPubMed Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:675–680.CrossRefPubMed
15.
Zurück zum Zitat Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604–611.CrossRefPubMed Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604–611.CrossRefPubMed
16.
Zurück zum Zitat Pfutzner A, Forst T. High sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther. 2006;8(1):28–36.CrossRefPubMed Pfutzner A, Forst T. High sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther. 2006;8(1):28–36.CrossRefPubMed
17.
Zurück zum Zitat Osei-Bimpong A, Meek JH, Lewis SM. ESR or CRP? A comparison of their clinical utility. Hematology. 2007;12(4):353–357.CrossRefPubMed Osei-Bimpong A, Meek JH, Lewis SM. ESR or CRP? A comparison of their clinical utility. Hematology. 2007;12(4):353–357.CrossRefPubMed
18.
Zurück zum Zitat Shilipak MG, Ix JH, et al. Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med. 2008;121(1):50–57.CrossRef Shilipak MG, Ix JH, et al. Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med. 2008;121(1):50–57.CrossRef
19.
Zurück zum Zitat Poole CD, Conway P, Currie CJ. An evaluation of the association between systemic inflammation-as measured by C-reactive protein—and hospital resource use. Curr Med Res Opin. 2007;23(11):2785–2792.CrossRefPubMed Poole CD, Conway P, Currie CJ. An evaluation of the association between systemic inflammation-as measured by C-reactive protein—and hospital resource use. Curr Med Res Opin. 2007;23(11):2785–2792.CrossRefPubMed
20.
21.
Zurück zum Zitat Grinspoon SK, Biller BMK. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994;79:923–931.CrossRefPubMed Grinspoon SK, Biller BMK. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994;79:923–931.CrossRefPubMed
Metadaten
Titel
Factors Contributing to Hospitalization for Gastroparesis Exacerbations
verfasst von
Sesha S. Uppalapati
Zeeshan Ramzan
Robert S. Fisher
Henry P. Parkman
Publikationsdatum
01.11.2009
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2009
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0975-1

Weitere Artikel der Ausgabe 11/2009

Digestive Diseases and Sciences 11/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.